Related Experiment Videos

Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?

J Rumi Jaumdally1, Chetan Varma, Gregory Y H Lip

  • 1Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, B18 7QH, UK.

Expert Opinion on Pharmacotherapy
|June 15, 2007
PubMed

Insights

Statins significantly reduce cardiovascular disease mortality and morbidity. This review examines their impact on South-Asians, a group with high coronary event rates and unique atheroma characteristics.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) poses a significant health burden globally.
  • 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) are proven effective in primary and secondary CVD prevention.
  • South-Asians exhibit a higher prevalence of early-onset coronary events and distinct atheroma patterns.

Purpose of the Study:

  • To review the impact of statin therapy in South-Asians.
  • To correlate statin efficacy with lipid profiles and novel vascular disease markers in this ethnic group.

Main Methods:

  • Literature review focusing on statin use in cardiovascular disease.
  • Analysis of studies reporting on South-Asian populations with coronary artery disease.
  • Examination of lipid profiles and emerging vascular biomarkers in relation to statin treatment.

Main Results:

  • Statins demonstrate efficacy in reducing cardiovascular events and halting atherosclerosis progression.
  • Observed lipid profiles and vascular markers in South-Asians warrant further investigation regarding statin response.
  • The unique atheroma characteristics in South-Asians may influence treatment outcomes.

Conclusions:

  • Statins are crucial for managing cardiovascular disease in all populations, including South-Asians.
  • Further research is needed to optimize statin therapy based on ethnic-specific lipid profiles and vascular markers.
  • Understanding these factors can improve cardiovascular event prevention in high-risk South-Asian populations.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...